Navigation Links
Kinetiq Announces the Addition of Key Executives; Two Will Speak at Upcoming Clinical Research Conferences
Date:4/14/2016

Kinetiq, a new division of Quorum Review IRB with a focus on providing consulting and IT services, is proud to announce the completion of its executive leadership team.

“I’m thrilled with the addition of our new leadership,” says Cami Gearhart, CEO. “Each of our new executives brings the talent and experience needed to keep Kinetiq at the forefront of providing services to the global clinical research community.”

Mitchell Parrish joins Kinetiq as Vice President of Legal Affairs. Mr. Parrish has served in both in-house and outside counsel roles focused on life sciences and human subject protection; he has been a consultant to the National Cancer Institute and an attorney with the global law firm K&L Gates. Mr. Parrish is a frequent speaker on clinical trial topics and is a published author on regulatory affairs. He is a member of the bar associations in Washington and Oregon, a member of the Regulatory Affairs Professionals Society, a Certified IRB Professional and holds Regulatory Affairs Certification. Mr. Parrish will co-present along with Dr. Owen Garrick, CEO of Bridge Clinical, at the ACRP Annual Meeting in a panel session titled “Social Media in Clinical Trial Patient Recruitment” on Saturday, April 16.

James Riddle joins Kinetiq as Vice President of Client Services. Prior to joining Kinetiq, Mr. Riddle served as Assistant Director at the Fred Hutchinson Cancer Research Center, one of the nation’s largest independent cancer research centers, and he has over 15 years of experience leading private and academic human subject protection programs. Mr. Riddle has served as a site visitor for the Association for Accreditation of Human Subject Protection Programs, is a faculty member, mentor, and regular speaker for Public Responsibility in Medicine and Research, has served on the Board of the Northwest Association for Biomedical Research and is a Certified IRB Professional. Mr. Riddle will present at the AAHRPP Annual Conference in a breakout session titled “Single IRB Review: Retooling Your Staff” on Wednesday, April 20.

Kyle Maeda has been selected to be the Vice President of Information Technology for Kinetiq. Mr. Maeda brings over 20 years of experience improving the performance of global technology firms. As a senior executive, Mr. Maeda has solved business transformation challenges in multiple industries focusing on global strategy and delivery excellence. Most recently, Mr. Maeda was principal of a cross-industry management consulting practice focused on the innovative use of technology. He also led the global IT team for a Fortune 200 manufacturing firm and provided mergers and acquisitions as well as technology leadership for a Global 1000 wireless carrier.

“The diverse leadership experience and strategic excellence of these executives will quickly position Kinetiq for growth as a leader in clinical trials consulting and software solutions,” said Tom Favillo, President and COO of Quorum.

Find out more about Kinetiq services at KinetiqIdeas.com.

About Kinetiq
Kinetiq is a consulting and technology division of Quorum that delivers innovative solutions to the challenges of human subjects protections and compliance in clinical research. Kinetiq works with clinical researchers, research institutions, pharmaceutical, biotechnology, and medical device companies—as well as others around the world—to develop contemporary approaches to a changing landscape.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13339923.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Opal Kelly Announces ZEM5305 Integration Module with Altera Cyclone V E and FrontPanel SDK
2. EY Announces Brian Meshkin, CEO at Proove Biosciences, as EY Entrepreneur Of The Year® 2016 Orange County Semifinalist for the 2nd Year in a Row
3. Genedata Announces the Release of Genedata Bioprocess - New Workflow Platform for Biopharmaceutical Development
4. SPIE Announces 2016 Award Recipients for Achievements in Optics and Photonics
5. DELVE HEALTH Announces New Advisory Board
6. CSM Announces Promotion of Brian Swites to President
7. Rocky Mountain Biologicals Announces Water for Injection (WFI) Manufacturing Facility in West Jordan, Utah
8. Temarry Recycling Announces That Exporting Hazardous Waste Eliminates Biennial Reporting Requirement
9. Charm Sciences Announces FDA Release of 2400 Forms for Charm Peel Plate AC and EC Microbial Tests
10. CfPIE Announces New Training Course on the Regulated Medical Marijuana Business
11. Global Stem Cells Group Announces Manufacturing Phase of Progenikine™ SVF Closed System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., ... and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson ...
(Date:7/7/2020)... ... , ... Bio-IT World has announced the winners of the ... of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were honored. ... examples of how technology innovations and strategic initiatives can be powerful forces for ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... procured purchasing contracts to its membership, recently named BioFit Engineered Products ... the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at ...
(Date:6/28/2020)... LAGUNA NIGUEL, Calif. (PRWEB) , ... June 25, 2020 , ... ... today announced the launch of Safe Space™ for businesses of all types to ensure ... and 3D LiDAR. , A Safe Space™ enabled business will provide a ...
Breaking Biology Technology:
(Date:8/12/2020)... ... August 12, 2020 , ... ... that are ideal for public health agencies of all sizes. With a focus ... helping at-risk individuals find appropriate health care, Mosio helps public health departments automate ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from the ... ProText™, making them the first Wharton’s jelly allografts to be assigned a Q code ... solutions are the first Wharton’s jelly allograft product to be recognized as a 361 ...
(Date:7/31/2020)... SAN FRANCISCO (PRWEB) , ... July 30, 2020 ... ... Therapeutics’ maturing prescription digital therapeutics product portfolio with a near term focus on ... diverse biotech and pharma commercialization experience across multiple therapeutic areas and classes. As ...
Breaking Biology News(10 mins):